Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Barbanoj

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology|June 28, 2006
Clinical pharmacokinetics of dexketoprofen trometamol: recent studiesM J Barbanoj
Revista De Neurologia|March 24, 2000
[Monoaminergic selectivity of the antidepressive drugs and sleep: neurophysiological implications of depression]J L Lorenzo, M J Barbanoj
Methods and Findings in Experimental and Clinical Pharmacology|February 11, 2003
Pharmaco-electroencephalography and pharmacokinetic/pharmacodynamic modeling in basic research: focus on human pharmacologyM Valle, M J Barbanoj, F Jané
Clinical Pharmacology and Therapeutics|October 3, 1998
Buspirone plasma concentrationsM J Barbanoj, P Parra, F Jané
Clinical Pharmacology and Therapeutics|June 1, 1995
Buspirone and electroencephalographyM J Barbanoj, R M Antonijoan, F Jané
Annals of Biomedical Engineering|November 6, 2008
Ocular reduction in EEG signals based on adaptive filtering, regression and blind source separationS Romero, M A Mañanas, M J Barbanoj
Clinical Pharmacokinetics|May 23, 2001
Clinical pharmacokinetics of dexketoprofenM J Barbanoj, R M Antonijoan, I Gich
Methods and Findings in Experimental and Clinical Pharmacology|June 1, 1993
Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: psychometric and psychophysiological evaluationJ Grünberger, B Saletu, L Linzmayer, et al.
British Journal of Clinical Pharmacology|October 1, 1995
Evaluation of the central effects of alcohol and caffeine interactionO Azcona, M J Barbanoj, J Torrent, et al.
Neuropsychobiology|January 1, 1993
Restriction to a limited set of EEG-target variables may lead to misinterpretation of pharmaco-EEG resultsP Anderer, M J Barbanoj, B Saletu, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Methods and Findings in Experimental and Clinical Pharmacology|June 28, 2006
Clinical pharmacokinetics of dexketoprofen trometamol: recent studiesM J Barbanoj
Revista De Neurologia|March 24, 2000
[Monoaminergic selectivity of the antidepressive drugs and sleep: neurophysiological implications of depression]J L Lorenzo, M J Barbanoj
Methods and Findings in Experimental and Clinical Pharmacology|February 11, 2003
Pharmaco-electroencephalography and pharmacokinetic/pharmacodynamic modeling in basic research: focus on human pharmacologyM Valle, M J Barbanoj, F Jané
Clinical Pharmacology and Therapeutics|October 3, 1998
Buspirone plasma concentrationsM J Barbanoj, P Parra, F Jané
Clinical Pharmacology and Therapeutics|June 1, 1995
Buspirone and electroencephalographyM J Barbanoj, R M Antonijoan, F Jané
Annals of Biomedical Engineering|November 6, 2008
Ocular reduction in EEG signals based on adaptive filtering, regression and blind source separationS Romero, M A Mañanas, M J Barbanoj
Clinical Pharmacokinetics|May 23, 2001
Clinical pharmacokinetics of dexketoprofenM J Barbanoj, R M Antonijoan, I Gich
Methods and Findings in Experimental and Clinical Pharmacology|June 1, 1993
Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: psychometric and psychophysiological evaluationJ Grünberger, B Saletu, L Linzmayer, et al.
British Journal of Clinical Pharmacology|October 1, 1995
Evaluation of the central effects of alcohol and caffeine interactionO Azcona, M J Barbanoj, J Torrent, et al.
Neuropsychobiology|January 1, 1993
Restriction to a limited set of EEG-target variables may lead to misinterpretation of pharmaco-EEG resultsP Anderer, M J Barbanoj, B Saletu, et al.
Pageof 6